Went public on 7/20/2000 at $12 per share

Filing Range: 3 mil. shares @ $11 to $12

Shares Outstanding: 12.1 mil. shares

Underwriters: Salomon Smith Barney/Stephens Inc./William Blair & Co.

Company Counsel: Dorsey & Whitney LLP

Manager Counsel: Katten Muchin & Zavis

Auditor: Ernst & Young LLP

The Company:

Develops proprietary vascular sealing devices that allows for rapid sealing of the arterial access sites following a catheterization procedure. The product uses a balloon catheter which is inserted through the introducer sheath that is already in the patient. The inflated balloon serves as a temporary mechanical seal, preventing the flow of blood from the artery. Our procoagulant, which is a proprietary mixture of thrombin, collagen and diluent, is then delivered to the puncture site, stimulating rapid clotting and creating a complete seal of both the arterial puncture and the tissue tract from the artery to the skin surface. With the Duett sealing device, nothing is left behind in the artery, so immediate reaccess of the site, if necessary, is possible, and the potential for infection is minimized.

Venture Backers:

Olympic Venture Partners

Tredegar Investments

Kirlan Venture Capital Inc.

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 01/01/1997 2 Early Stage 1500.0

2 12/29/1997 3 Expansion 6999.9

3 12/10/1998 5 Expansion 8000.1


(Data in $ millions)



Total Revenues: $1.4

Net Income: -7.9